SCHEMBL8633713

SCHEMBL8633713

C#Cc1c(C(=O)O)cccc1-c1ccc2c(c1)N=C(OC(C)C)CC2(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 6/20 0.33
RXRA P19793 3/20 0.33
RARG P13631 3/20 0.33
RXRB P28702 2/20 0.33
RARA P10276 5/20 0.31
S1PR1 P21453 1/20 0.31
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
RXRG P48443 1/20 0.30
MAP3K5 Q99683 1/20 0.30
ADRB3 P13945 3/20 0.30
ADRB1 P08588 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8651566 0.93 RARB (0.33) RARBRXRARARGRXRBRARA
SCHEMBL8660641 0.73 RARB (0.36) RARBRXRARARGRARA
SCHEMBL8772664 0.72 RARB (0.40) RARBRXRARARGRARA
SCHEMBL8648772 0.71 RARB (0.36) RARBRXRARARGRARA
SCHEMBL8772694 0.70 RARG (0.42) RARBRXRARARGRXRBRARA
SCHEMBL8772752 0.70 RARB (0.36) RARBRXRARARGRARA
SCHEMBL8772633 0.69 RARB (0.47) RARBRXRARARGRARA
SCHEMBL8666520 0.69 RARB (0.38) RARBRARGRARA
SCHEMBL8562392 0.68 RARB (0.42) RARBRXRARARGRARAMEN1
SCHEMBL8772662 0.68 RARB (0.42) RARBRXRARARGRARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825986-A1 QUINOLYL-ETHYNYL DERIVATIVES HAVING RETINOID-LIKE ACTIVITY Allergan (US) 1998-03-04 EP disclosed
WO-1996036609-A1 QUINOLYL-ETHYNYL DERIVATIVES HAVING RETINOID-LIKE ACTIVITY ALLERGAN (US) 1996-11-21 WO disclosed